Client Overview
The client is a US-based generic or generics-focused pharmaceutical company requiring support for Annual Report compilation and submission to the US FDA. The engagement centered on ensuring compliant annual reporting through coordinated Regulatory and publishing support.
Client Background
The client needed a partner to manage the end-to-end process for annual report compilation, evaluation, and submission. This included aligning documentation, coordinating with publishing teams and US local agents, and ensuring submission through the Electronic Submission Gateway within agency timelines.
Services in Scope
Compilation and evaluation of Annual Report content for US FDA submission.
Coordination with publishing teams and US local agents.
Final submission of the Annual Report through the Electronic Submission Gateway (ESG).
Regulatory guidance to ensure the report met applicable reporting expectations.
Challenges
Stringent submission timelines for Annual Report delivery.
Need to validate and update multiple supporting documents before submission.
Requirement to maintain compliance while coordinating across functions and submission partners.
Solution
Freyr implemented a structured annual reporting workflow that combined document review, cross-functional coordination, and timeline-driven publishing. This approach ensured that content was complete, up to date, and submitted in the required format without disrupting compliance obligations.
1
Compiled and evaluated Annual Report source content as per US FDA reporting expectations.
2
Reviewed and updated supporting documents to close gaps before submission.
3
Coordinated with publishing teams and US local agents to prepare the submission package.
4
Submitted the final Annual Report through the ESG within the required timeline.
Freyr helped the US client turn a time-sensitive reporting need into a controlled, compliant process. By combining document review with coordinated publishing, the engagement eased operational pressure and ensured market continuity.
